Article info
PDFCorrespondence
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease
- Correspondence to Dr Ambrogio Orlando, Division of Internal Medicine, “Villa Sofia-V. Cervello” Hospital, Palermo 90146, Italy; ambrogiorlando{at}gmail.com
Citation
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease
Publication history
- Received December 21, 2016
- Revised December 27, 2016
- Accepted December 28, 2016
- First published January 17, 2017.
Online issue publication
August 10, 2017
Article Versions
- Previous version (17 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/